Alexander Glen Wright, MD | |
3650 Piper Street Ste A, Anchorage, AK 99508 | |
(907) 339-9455 | |
(907) 339-9445 |
Full Name | Alexander Glen Wright |
---|---|
Gender | Male |
Speciality | Diagnostic Radiology |
Experience | 12 Years |
Location | 3650 Piper Street Ste A, Anchorage, Alaska |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1396011300 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0202X | Radiology - Diagnostic Radiology | A146981 (California) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Lee Memorial Hospital | Fort myers, FL | Hospital |
Gulf Coast Medical Center Lee Health | Fort myers, FL | Hospital |
Cape Coral Hospital | Cape coral, FL | Hospital |
Kettering Medical Center | Kettering, OH | Hospital |
Soin Medical Center | Beaver creek, OH | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Kettering Network Radiologists Inc | 7618960303 | 66 |
Florida Radiology Consultants P A | 3678471943 | 45 |
Kettering Network Radiologists Inc | 7618960303 | 66 |
Kettering Network Radiologists Inc | 7618960303 | 66 |
News Archive
Carnegie Mellon University scientists Timothy Keller and Marcel Just have uncovered the first evidence that intensive instruction to improve reading skills in young children causes the brain to physically rewire itself, creating new white matter that improves communication within the brain.
Omeros Corporation today announced that patient enrollment has begun in the Company's second Phase 3 clinical trial evaluating OMS302 in intraocular lens replacement (ILR) surgery.
Researchers at Cedars-Sinai Medical Center and 50 other centers found that weight-based dosing of taribavirin reduces rates of anemia while increasing sustained virologic response (SVR) in patients with chronic hepatitis C (HCV). Full details of this study are available in the October issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases (AASLD).
U.S. District Judge Edward Korman in New York on Monday ordered FDA to reconsider allowing 17-year-old girls access to the morning-after pill Plan B without a prescription within the next 30 days and consider allowing access to the pill for women of all ages (Stein, Washington Post, 3/24).
Avila Therapeutics, Inc., a biotechnology company developing novel covalent drugs that treat diseases through protein silencing, presented results of preclinical studies on its highly selective, pan-genotype, small molecule Hepatitis C Virus (HCV) protease inhibitor, AVL-181.
› Verified 7 days ago
Entity Name | County Of Los Angeles |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1851363188 PECOS PAC ID: 1850296534 Enrollment ID: O20031204001218 |
News Archive
Carnegie Mellon University scientists Timothy Keller and Marcel Just have uncovered the first evidence that intensive instruction to improve reading skills in young children causes the brain to physically rewire itself, creating new white matter that improves communication within the brain.
Omeros Corporation today announced that patient enrollment has begun in the Company's second Phase 3 clinical trial evaluating OMS302 in intraocular lens replacement (ILR) surgery.
Researchers at Cedars-Sinai Medical Center and 50 other centers found that weight-based dosing of taribavirin reduces rates of anemia while increasing sustained virologic response (SVR) in patients with chronic hepatitis C (HCV). Full details of this study are available in the October issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases (AASLD).
U.S. District Judge Edward Korman in New York on Monday ordered FDA to reconsider allowing 17-year-old girls access to the morning-after pill Plan B without a prescription within the next 30 days and consider allowing access to the pill for women of all ages (Stein, Washington Post, 3/24).
Avila Therapeutics, Inc., a biotechnology company developing novel covalent drugs that treat diseases through protein silencing, presented results of preclinical studies on its highly selective, pan-genotype, small molecule Hepatitis C Virus (HCV) protease inhibitor, AVL-181.
› Verified 7 days ago
Entity Name | Regents Of The University Of California |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1558463927 PECOS PAC ID: 3577476761 Enrollment ID: O20040107000584 |
News Archive
Carnegie Mellon University scientists Timothy Keller and Marcel Just have uncovered the first evidence that intensive instruction to improve reading skills in young children causes the brain to physically rewire itself, creating new white matter that improves communication within the brain.
Omeros Corporation today announced that patient enrollment has begun in the Company's second Phase 3 clinical trial evaluating OMS302 in intraocular lens replacement (ILR) surgery.
Researchers at Cedars-Sinai Medical Center and 50 other centers found that weight-based dosing of taribavirin reduces rates of anemia while increasing sustained virologic response (SVR) in patients with chronic hepatitis C (HCV). Full details of this study are available in the October issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases (AASLD).
U.S. District Judge Edward Korman in New York on Monday ordered FDA to reconsider allowing 17-year-old girls access to the morning-after pill Plan B without a prescription within the next 30 days and consider allowing access to the pill for women of all ages (Stein, Washington Post, 3/24).
Avila Therapeutics, Inc., a biotechnology company developing novel covalent drugs that treat diseases through protein silencing, presented results of preclinical studies on its highly selective, pan-genotype, small molecule Hepatitis C Virus (HCV) protease inhibitor, AVL-181.
› Verified 7 days ago
Entity Name | Kern Radiology Medical Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1700821972 PECOS PAC ID: 7214826460 Enrollment ID: O20040315000421 |
News Archive
Carnegie Mellon University scientists Timothy Keller and Marcel Just have uncovered the first evidence that intensive instruction to improve reading skills in young children causes the brain to physically rewire itself, creating new white matter that improves communication within the brain.
Omeros Corporation today announced that patient enrollment has begun in the Company's second Phase 3 clinical trial evaluating OMS302 in intraocular lens replacement (ILR) surgery.
Researchers at Cedars-Sinai Medical Center and 50 other centers found that weight-based dosing of taribavirin reduces rates of anemia while increasing sustained virologic response (SVR) in patients with chronic hepatitis C (HCV). Full details of this study are available in the October issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases (AASLD).
U.S. District Judge Edward Korman in New York on Monday ordered FDA to reconsider allowing 17-year-old girls access to the morning-after pill Plan B without a prescription within the next 30 days and consider allowing access to the pill for women of all ages (Stein, Washington Post, 3/24).
Avila Therapeutics, Inc., a biotechnology company developing novel covalent drugs that treat diseases through protein silencing, presented results of preclinical studies on its highly selective, pan-genotype, small molecule Hepatitis C Virus (HCV) protease inhibitor, AVL-181.
› Verified 7 days ago
Entity Name | Regents Of The University Of California Ucsd Department Of Radiology |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1225213655 PECOS PAC ID: 8224108741 Enrollment ID: O20080610000132 |
News Archive
Carnegie Mellon University scientists Timothy Keller and Marcel Just have uncovered the first evidence that intensive instruction to improve reading skills in young children causes the brain to physically rewire itself, creating new white matter that improves communication within the brain.
Omeros Corporation today announced that patient enrollment has begun in the Company's second Phase 3 clinical trial evaluating OMS302 in intraocular lens replacement (ILR) surgery.
Researchers at Cedars-Sinai Medical Center and 50 other centers found that weight-based dosing of taribavirin reduces rates of anemia while increasing sustained virologic response (SVR) in patients with chronic hepatitis C (HCV). Full details of this study are available in the October issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases (AASLD).
U.S. District Judge Edward Korman in New York on Monday ordered FDA to reconsider allowing 17-year-old girls access to the morning-after pill Plan B without a prescription within the next 30 days and consider allowing access to the pill for women of all ages (Stein, Washington Post, 3/24).
Avila Therapeutics, Inc., a biotechnology company developing novel covalent drugs that treat diseases through protein silencing, presented results of preclinical studies on its highly selective, pan-genotype, small molecule Hepatitis C Virus (HCV) protease inhibitor, AVL-181.
› Verified 7 days ago
Entity Name | Kettering Network Radiologists Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1346299153 PECOS PAC ID: 7618960303 Enrollment ID: O20170209001203 |
News Archive
Carnegie Mellon University scientists Timothy Keller and Marcel Just have uncovered the first evidence that intensive instruction to improve reading skills in young children causes the brain to physically rewire itself, creating new white matter that improves communication within the brain.
Omeros Corporation today announced that patient enrollment has begun in the Company's second Phase 3 clinical trial evaluating OMS302 in intraocular lens replacement (ILR) surgery.
Researchers at Cedars-Sinai Medical Center and 50 other centers found that weight-based dosing of taribavirin reduces rates of anemia while increasing sustained virologic response (SVR) in patients with chronic hepatitis C (HCV). Full details of this study are available in the October issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases (AASLD).
U.S. District Judge Edward Korman in New York on Monday ordered FDA to reconsider allowing 17-year-old girls access to the morning-after pill Plan B without a prescription within the next 30 days and consider allowing access to the pill for women of all ages (Stein, Washington Post, 3/24).
Avila Therapeutics, Inc., a biotechnology company developing novel covalent drugs that treat diseases through protein silencing, presented results of preclinical studies on its highly selective, pan-genotype, small molecule Hepatitis C Virus (HCV) protease inhibitor, AVL-181.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Alexander Glen Wright, MD 3650 Piper Street Ste A, Anchorage, AK 99508 Ph: (907) 339-9455 | Alexander Glen Wright, MD 3650 Piper Street Ste A, Anchorage, AK 99508 Ph: (907) 339-9455 |
News Archive
Carnegie Mellon University scientists Timothy Keller and Marcel Just have uncovered the first evidence that intensive instruction to improve reading skills in young children causes the brain to physically rewire itself, creating new white matter that improves communication within the brain.
Omeros Corporation today announced that patient enrollment has begun in the Company's second Phase 3 clinical trial evaluating OMS302 in intraocular lens replacement (ILR) surgery.
Researchers at Cedars-Sinai Medical Center and 50 other centers found that weight-based dosing of taribavirin reduces rates of anemia while increasing sustained virologic response (SVR) in patients with chronic hepatitis C (HCV). Full details of this study are available in the October issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases (AASLD).
U.S. District Judge Edward Korman in New York on Monday ordered FDA to reconsider allowing 17-year-old girls access to the morning-after pill Plan B without a prescription within the next 30 days and consider allowing access to the pill for women of all ages (Stein, Washington Post, 3/24).
Avila Therapeutics, Inc., a biotechnology company developing novel covalent drugs that treat diseases through protein silencing, presented results of preclinical studies on its highly selective, pan-genotype, small molecule Hepatitis C Virus (HCV) protease inhibitor, AVL-181.
› Verified 7 days ago
Michael James Mcdonnell, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 4315 Diplomacy Dr, Anchorage, AK 99508 Phone: 907-563-2662 | |
William Patton Perry, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2751 Debarr Rd Ste B360, Anchorage, AK 99508 Phone: 907-792-7920 | |
Burl C Stephens, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 4315 Diplomacy Dr, Attn: Sherry Reedy, Anchorage, AK 99508 Phone: 907-729-3971 Fax: 907-729-1542 | |
Dr. Matthew Raymond Minor, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3650 Piper St Ste A, Anchorage, AK 99508 Phone: 907-339-9455 Fax: 907-339-9445 | |
Dr. Gerald Edward York Ii, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 3650 Piper Street Suite A, Anchorage, AK 99508 Phone: 907-222-4624 Fax: 907-222-4651 | |
John Mccormick, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2110 E Northern Lights Blvd, Anchorage, AK 99508 Phone: 907-563-3700 Fax: 907-563-3740 | |
Dr. Wandal Bryan Winn, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3200 Providence Dr, Anchorage, AK 99508 Phone: 907-339-9455 Fax: 907-339-9445 |